New York, NY · Founded 2020 · Privately Held (backing)
Developer of clinical-stage drugs designed for the treatment of autoimmune, cancer, and other serious diseases. Graviton BioScience is based in New York, NY and was founded in 2020. It was valued at $264 million at its early-stage round in Feb 2024, the last priced event on record. It has raised $93.3 million across 4 recorded rounds; the latest was a $25 million early-stage round in Jan 2024.
These 6 firms already write checks for companies like Graviton BioScience. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.